§ 13F · FUND PROFILE
Rosalind Advisors, Inc..
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · $293M (13F)Positions · 39Turnover · — · Q1Filed · May 14, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$65M deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q1 2026
FILED MAY 14, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q1 |
|---|---|---|---|---|---|---|
| 1 | DCTH | DELCATH SYSTEMS, INC. | 3.30M | $31M | 12.3% | ±0% |
| 2 | XERS | XERIS BIOPHARMA HOLDINGS INC | 3.23M | $19M | 7.5% | +53% |
| 3 | FENC | FENNEC PHARMACEUTICALS INC | 2.91M | $18M | 7.2% | +11% |
| 4 | SVRA | SAVARA INC | 3.20M | $17M | 7.0% | −6% |
| 5 | PCVX | VAXCYTE INC | 290K | $17M | 6.8% | NEW |
| 6 | EYPT | EYEPOINT PHARMACEUTICALS INC | 1.04M | $13M | 5.4% | +50% |
| 7 | XFOR | X4 PHARMACEUTICALS INC | 3.21M | $13M | 5.3% | +23% |
| 8 | VOR | VOR BIOPHARMA INC | 700K | $12M | 5.0% | NEW |
| 9 | MDWD | MEDIWOUND LTD | 749K | $12M | 4.8% | ±0% |
| 10 | VSTM | VERASTEM INC | 2.14M | $11M | 4.6% | +20% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE ROSALIND SIGNAL
AC read
Rosalind Advisors, Inc. is a Other fund managing $293 million in assets. The fund runs a portfolio of 39 positions.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
2 FILINGS
Q1 2026
Steady book
+0 buys · −0 exits · 0 changed
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q3 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed